Madras High Court Clarifies Bolar Exemption Criteria for Pharmaceutical Exports
In Novartis AG v. Venkata Narayana Active Ingredients, the Madras High Court provided clarity on the evidentiary requirements for invoking Section 107A of the Patents Act regarding exports for regulatory approval. The judgment aims to balance patent rights with the need for accessible medicines.

